BBA
APVO icon

Baader Bank Aktiengesellschaft’s Aptevo Therapeutics APVO Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio APVO Stock Details APVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2
Closed -$5.02K – 449
2024
Q2 		$5.02K Buy
+2
New +$29.9K ﹤0.01% 406
2024
Q1 		– Hold
0
– -$2.03K – 325
2023
Q4 		– Hold
0
– – – 313

Other funds holding APVO

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Baader Bank Aktiengesellschaft's APVO Position: Q3 2024 in Review

Baader Bank Aktiengesellschaft sold out of Aptevo Therapeutics (APVO) in Q3 2024, closing a stake of 2 shares — an estimated $5.02K sold.

Baader Bank Aktiengesellschaft first reported a position in APVO in Q2 2024 and held it in 1 quarter. The position peaked at $5.02K in Q2 2024. 10 funds tracked by Wall St. Rank hold APVO as of Q3 2024.

  • Baader Bank Aktiengesellschaft reported no remaining Aptevo Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 2 Aptevo Therapeutics shares in Q3 2024, an estimated $5.02K.
  • Baader Bank Aktiengesellschaft first reported a position in Aptevo Therapeutics in Q2 2024 and held it in 1 quarter.
  • Baader Bank Aktiengesellschaft's Aptevo Therapeutics position peaked at $5.02K in Q2 2024.
  • 10 funds tracked by Wall St. Rank held Aptevo Therapeutics as of Q3 2024.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q3 2024, filed 29 Oct 2024.